Ask KHN-PolitiFact: How Can Covid Vaccines Be Safe When They Were Developed So Fast?
Experts say there's nothing new about the research underpinning the covid vaccines and that they were tested in more participants than many other approved vaccines.
Drugs
541-560 of 1,312 results
-
-
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
-
How Much of Trump’s Health Agenda Has Biden Undone?
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
By Julie Rovner -
KHN’s ‘What the Health?’: Getting Down to Work at HHS
After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.
-
Democrats Eye Medicare Negotiations to Lower Drug Prices
Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.
-
The Case for Donating US Covid Vaccines Overseas
For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.
By Arthur Allen -
KHN’s ‘What the Health?’: ACA Packs More Benefits — And More Confusion
The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.
-
POSTCARD FROM LONG BEACH
‘Super-Sized’ Vaccine Clinic Offers Food Workers Some Relief
Long Beach, which has its own health department, kicked off a vaccination campaign for essential workers by inviting 3,000 food workers to a splashy vaccination event at the city’s convention center.
By Lori Basheda -
Doctors Debate Use of Blood Thinners to Prevent Clots in Women After C-Sections
One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, questioning whether wide use of the drug is effective, worth the cost and safe, since it carries the risk of bleeding.
By Harris Meyer -
High Obesity Rates in Southern States Magnify Covid Threat
In the American South — home to nine of the nation’s 12 heaviest states — obesity is playing a role not only in covid outcomes, but in the calculus of the vaccination rollout.
By Sarah Varney -
Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues, History of Recalls
After nearly a decade’s worth of federal inspections, reprimands and corrective action plans, has Pfizer fixed the facility that will be filling vials of its covid vaccine?
-
KHN’s ‘What the Health?’: Good and Not-So-Good News on Covid
The FDA authorized the emergency use of a one-shot vaccine made by Johnson & Johnson, which could help accelerate the pace of vaccinations to prevent covid-19. But after a dramatic decline, case numbers are again rising, and several states are rolling back public health mitigation efforts. Mary Ellen McIntire of CQ Roll Call, Joanne Kenen of Politico and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Jordan Rau about the latest KHN-NPR “Bill of the Month” episode.
-
Accidentally Trashed, Thawed or Expired: Reports of Covid Vaccine Spoilage
As the speed of covid vaccinations picks up, so do the reports of doses going to waste. Health officials are trying to rein in waste without slowing down vaccinations.
-
In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites
Parents and caregivers of people with disabilities in California are supposed to be near the front of the line for the covid-19 vaccine. But some are hitting roadblocks at vaccination sites.
-
Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America
Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever — which are still painfully slow, critics say.
-
After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply?
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.
By Rachana Pradhan and Arthur Allen -
KHN’s ‘What the Health?’: Open Enrollment, One More Time
Keeping a campaign promise, President Joe Biden has reopened enrollment for health coverage under the Affordable Care Act on healthcare.gov — and states that run their own health insurance marketplaces followed suit. At the same time, the Biden administration is moving to revoke the Trump administration’s permission for states to impose work requirements for some adults on the Medicaid health insurance program. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews medical student Inam Sakinah, president of the new group Future Doctors in Politics.
-
Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple
Industry experts say it’s highly unlikely that dozens of pharmaceutical companies that aren’t already producing covid vaccines stand ready to do so.
-
As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
By Harris Meyer -
Farmworker Camps to Urban Tent Cities: Tailoring Vaccine Info to Where It’s Most Needed
Concerns arising in western North Carolina provide a window into the challenges facing health workers across the country as they seek to persuade vulnerable populations to be inoculated against covid.